Gilead Sciences | Satış

Hisse Senedi Fiyatı
151.41
Günlük Değişim
-1.09 -0.71%
Aylık
23.50%
Yıllık
58.58%
Q1 Tahmin
147.82




Satış Değişiklik Tarih
AbbVie USD 16.62B 840M 2025-12
Agios Pharmaceuticals USD 12.9M 450K 2025-09
ALKERMES USD 394.2M 3.5M 2025-09
Alnylam Pharmaceuticals USD 1.25B 476.31M 2025-09
Amgen USD 9.9B 340M 2025-12
Biogen USD 2.28B 250M 2025-12
BioMarin Pharmaceutical USD 776M 49M 2025-09
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Gilead Sciences USD 7.8B 700M 2025-09
GlaxoSmithKline GBP 8.62B 73M 2025-12
Glaxosmithkline GBP 11.52B 3.54B 2025-09
Incyte USD 1.37B 310M 2025-09
J&J USD 24.6B 610M 2025-12
Merck USD 16.4B 880M 2025-12
Moderna USD 1.02B 878M 2025-09
Neurocrine Biosciences USD 794.9M 107.4M 2025-09
Novartis USD 13.91B 144M 2025-09
Pfizer USD 17.58B 880M 2025-12
PTC Therapeutics USD 211M 32.1M 2025-09
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Sanofi EUR 11.3B 1.13B 2025-12
Sarepta Therapeutics USD 399.4M 211.69M 2025-09
United Therapeutics USD 799.5M 900K 2025-09
Vertex Pharmaceuticals USD 3.08B 120M 2025-09


Gilead Sciences Satış - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Feb 2026.